The Latest Cardiac and Vascular News
Novel device designed to address the root cause of mitral regurgitation, avoiding the need for open-heart surgery Company seeks partner to conduct a pivotal study in pursuit of a heart failure indication Clinical data supporting CE Mark to be presented as a late-breaking oral presentation at the virtual AATS 101st […]
SyncAR™ Technology Uniquely Integrates with StealthStation™ S8 Surgical Navigation System and Expands the Use of Augmented Reality Into Operating Rooms to Enhance Precision and Efficiency DUBLIN and LOS ANGELES, April 26, 2021 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, and Surgical Theater today announced a partnership to interface Surgical Theater’s SyncAR™ augmented reality (AR) […]
Second Biotherapeutic Partnership of 2021 SAN CARLOS, Calif., April 26, 2021 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], today announced that it has entered into an agreement with a leading Japanese biotechnology company related to BioCardia Helix catheter biotherapeutic delivery product candidates. Under the terms of the agreement, BioCardia will receive $500,000, […]
Aging Baby Boomer Population and Urgent Need During Pandemic Fuels Rapid Growth for Remote Cardiac Monitoring BEND, Ore.–(BUSINESS WIRE)–Vector Remote Care, a pioneering cardiac digital health provider, today announced it has closed a $12.5 million Series A investment led by Updata Partners. The funding will be used to accelerate product, […]
Case series demonstrates the advantages of transvenous active-fixation Tempo Lead over epicardial leads for minimally invasive cardiac surgery procedures MENLO PARK, Calif.–(BUSINESS WIRE)–BioTrace Medical, Inc., the leader in innovative temporary cardiac pacing technology, today announced the company’s Tempo® Temporary Pacing Lead was featured in a patient case series presented at the […]
Large routine clinical practice study, ETNA-AF-Europe, demonstrates continued benefits of edoxaban across age groups and supports treatment in elderly patient populations, in line with those observed in ETNA-AF after one year and in ENGAGE AF-TIMI 48 ETNA-AF-Europe is part of the global ETNA-AF programme, which is the largest prospective, non-interventional […]
The National Institute for Health and Care Excellence (NICE) finds HeartFlow Analysis can save NHS England as much as £391 per patient The digital technology is reducing reliance on unnecessary invasive diagnostic procedures and is cutting hospital waiting times The announcement follows NHS England’s MedTech Funding mandate, which went into effect on 01 […]
Accomplished entrepreneur with history of working in venture capital and private equity industry brings decades of experience in medical device innovation and commercialization to the fast-growing startup BOSTON, April 22, 2021 /PRNewswire/ — BIOMODEX®, a pioneering digital health company that offers advanced 3D printed solutions for patient-specific rehearsal and physician training, today announced […]
VAZKEPA (icosapent ethyl) is the first and only authorized treatment for its cardiovascular risk reduction indication1,2,3 VAZKEPA authorization for Great Britain follows recent VAZKEPA authorization for European Union DUBLIN, Ireland and BRIDGEWATER, N.J., April 22, 2021 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ: AMRN) today announced that the Medicines and […]
MILPITAS, Calif.–(BUSINESS WIRE)–Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, today announced that the BIOADAPTOR randomized controlled trial (RCT) is expanding to centers in Belgium and Germany. The BIOADAPTOR RCT is evaluating the DynamX™ Coronary Bioadaptor System, the first drug-eluting coronary artery implant that adapts to vessel physiology. The BIOADAPTOR […]
